Hematopoietic stem cell regulation by the Notch signaling-including hematopoietic stem cell induction from human embryonic stem cells-
Hematopoietic stem cell regulation by the Notch signaling-including hematopoietic stem cell induction from human embryonic stem cells-
批准号:
17390274
负责人:
CHIBA Shigeru
金额:
$9.86万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
Notch信号使造血干细胞(HSC)在体外扩增的同时保持其不成熟。然而,Notch信号是否在造血干细胞自我更新的骨髓生态位中起重要作用还有待确定。在这个项目中,我们的目标是通过使用缺乏Notch1和/或Notch2基因的小鼠或使用YO01027(一种Notch信号抑制剂)的野生型小鼠来解决这个问题。首先,我们比较了Notchl+/- notch2 +/-小鼠在给予5-FU后骨髓中恢复的Lin-Scal+cKit+ (LSK)细胞或CD34-LSK细胞的绝对数量,或野生型小鼠在给予5-FU后再给予YO01027。然而,与我们的预期相反,我们无法在两种实验中发现与对照小鼠的差异,因此,没有证据支持Notch信号在骨髓HSC维持中起生理作用的假设。从人类胚胎干细胞(ES)成功诱导造血干细胞使我们能够考虑这些造血干细胞的各种应用,例如临床使用导向的血细胞的工业化生产。在本项目中,基于我们之前发现Notch信号在胚胎发生过程中对HSC的产生起重要作用,我们研究了人类胚胎干细胞是否可以产生HSC。我们从人类胚胎干细胞系KhES-3诱导分化,并使用可能代表HSC的各种表面标记(如CD34、CD133、KDR、CD90、CD150、CD105、PCLP-1、PECAM1和VE-Cadherin)组合对胚胎干细胞来源的细胞进行分类。然而,那些被分类的细胞显示出分化为内皮细胞和巨噬细胞的潜力,但我们无法识别出具有显着造血活性的细胞。
英文摘要
Notch signaling enables the hematopoietic stem cells (HSC) to expand ex vivo while maintaining their immaturity. It is, however, to be determined whether the Notch signaling plays an important role in the bone marrow niche for the self HSC renewal. In this project, we aimed at approaching this question by using mice variably lacking Notch1 and/or Notch2 genes or wild-type mice administered with YO01027, a Notch signaling inhibitor. First, we compared the absolute number of recovering Lin-Scal+cKit+ (LSK) cells or CD34-LSK cells in the bone marrow of Notchl+/-Notch2+/- mice after administration with 5-FU, or wild-type mice administered with 5-FU followed by the YO01027 administration. Contrary to our expectation, however, we were unable to find the difference in either kind of experiment, compared with the control mice, and thus, no proof was obtained supporting the hypothesis that Notch signaling plays a physiological role in the HSC maintenance in the bone marrow.The successful induction of HSC from human embryonic stem (ES) cells allows us to consider various applications of those HSC, such as the industrialized production of clinical use-oriented blood cells. In this project, we investigated whether the HSC could be generated from human ES cells, based on our previous finding that Notch signaling plays an important role in HSC generation during embryogenesis. We induced differentiation from a human ES cell line, KhES-3, and sorted ES cell-derived cells using various combinations of surface markers that potentially represent HSC, such as CD34, CD133, KDR, CD90, CD150, CD105, PCLP-1, PECAM1, and VE-Cadherin. Those that were sorted as such, however, showed the potential to differentiate into endothelial cells and macrophages, but we were unable to identify the cells showing remarkable hematopoietic actiity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Treatment results of chemoradiation therapy for localized aggressive lymphomas : A retrospective 20-year study.
局部侵袭性淋巴瘤放化疗的治疗结果:一项回顾性 20 年研究。
DOI:
--
发表时间:
2006
期刊:
Ann Hematol 85(8)
影响因子:
--
作者:
[Yamashita H, Izutsu K, Nakamura N, Shiraishi K, Chiba S, Kurokawa M, Tago M, Igaki H, Ohtomo K, Nakagawa K]
通讯作者:
Nakagawa K
DOI:
10.4049/jimmunol.174.6.3526
发表时间:
2005-03-15
期刊:
JOURNAL OF IMMUNOLOGY
影响因子:
4.4
作者:
[Kawazu, M, Asai, T, Hirai, H]
通讯作者:
Hirai, H
Antineoplastic effect of a single oral dose of the novel Flt3 inhibitor KRN383 on xenografted human leukemic cells harboring Flt3-activating mutations.
单剂量口服新型 Flt3 抑制剂 KRN383 对携带 Flt3 激活突变的异种移植人类白血病细胞的抗肿瘤作用。
DOI:
--
发表时间:
2006
期刊:
Leuk Res 30
影响因子:
--
作者:
[Nishiyama U, et al.]
通讯作者:
et al.
DOI:
10.1016/j.exphem.2005.09.001
发表时间:
2005-12-01
期刊:
EXPERIMENTAL HEMATOLOGY
影响因子:
2.6
作者:
[Crcareva, A, Saito, T, Chiba, S]
通讯作者:
Chiba, S
DOI:
10.1002/gcc.20303
发表时间:
2006-05-01
期刊:
GENES CHROMOSOMES & CANCER
影响因子:
3.7
作者:
[Hosoya, N, Sanada, M, Ogawa, S]
通讯作者:
Ogawa, S
共 17 条
Origin of inflammatory cells constituting malignant lymphoma tissue
-
批准号:25670444
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2013
-
负责人:CHIBA Shigeru
-
依托单位:
TET2 gene abnormality and epigenetic dysregulation in hematologic malignancies
-
批准号:24390241
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.48万
-
财政年份:2012
-
负责人:CHIBA Shigeru
-
依托单位:
Pathophysiology of myelodyspoastic syndrome - network between bone marrow and nervus system
-
批准号:23659482
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:CHIBA Shigeru
-
依托单位:
A Study on modularization mechanisms to integrate hierarchical and crosscutting decomposition for the post-aspect era
-
批准号:22240002
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$31.7万
-
财政年份:2010
-
负责人:CHIBA Shigeru
-
依托单位:
Role of cell environmental signaling in the establishment of hematopoietic malignancies
-
批准号:19390258
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.98万
-
财政年份:2007
-
负责人:CHIBA Shigeru
-
依托单位:
A study on new modularization technology for software
-
批准号:19500023
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2007
-
负责人:CHIBA Shigeru
-
依托单位:
Assessment of immune modulation by Notch signaling-exploration of immunomodulatory intervention targeting Notch system.
-
批准号:14370300
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.23万
-
财政年份:2002
-
负责人:CHIBA Shigeru
-
依托单位:
DEVELOPMENT OF IMMUNOTHERAPY To HEMATOLOGIC MALIGNANCIES
-
批准号:13557080
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.9万
-
财政年份:2001
-
负责人:CHIBA Shigeru
-
依托单位:
Notch in hematopoiesis
-
批准号:11670980
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:1999
-
负责人:CHIBA Shigeru
-
依托单位:
Ex vivo expansion of hematopoietic stem cells using adenovirus
-
批准号:09671091
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:1997
-
负责人:CHIBA Shigeru
-
依托单位:
海外基金